Literature DB >> 10530461

Persistent Bacillus licheniformis bacteremia associated with an international injection of organic drain cleaner.

W N Hannah1, P T Ender.   

Abstract

In recent years manufacturers have developed several products containing saprophytic bacteria, previously believed to be of minimal pathogenicity. We describe the first case of persistent Bacillus licheniformis bacteremia occurring after intentional injection of a consumer product that includes B. licheniformis spores. We postulate that these spores remained in the tissue, unaffected by antimicrobials, ultimately necessitating soft-tissue debridement of the area surrounding the injection site. On the basis of this case and a review of the literature, we submit that some consumer products contain bacteria with demonstrated pathogenicity. Manufacturers should study these bacteria in detail in order to rapidly provide information such as bacteriologic data and antimicrobial susceptibility data to clinicians.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10530461     DOI: 10.1086/598647

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

1.  In vitro activities of daptomycin, ciprofloxacin, and other antimicrobial agents against the cells and spores of clinical isolates of Bacillus species.

Authors:  Diane M Citron; Maria D Appleman
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

2.  Bacteremia due to three Bacillus species in a case of Munchausen's syndrome.

Authors:  Jason Galanos; Shalinie Perera; Haydn Smith; David O'Neal; Harsha Sheorey; Mary Jo Waters
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

3.  Recurrent sepsis due to bacillus licheniformis.

Authors:  Irina A Haydushka; Nadya Markova; Vesselina Kirina; Maria Atanassova
Journal:  J Glob Infect Dis       Date:  2012-01

4.  Clostridium tertium bacteremia in a patient with glyphosate ingestion.

Authors:  Myung-Jo You; Gee-Wook Shin; Chang-Seop Lee
Journal:  Am J Case Rep       Date:  2015-01-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.